| ￥800 | |
| Z05012-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | |
| Protein Construction |
|
|
| Purity |
>?95%?as?determined?by?Bis?Tris?PAGE? >?95%?as?determined?by?HPLC |
|
| Endotoxin Level | Less than 1EU per μg by the LAL method. | |
| Expression System | E.coli | |
| Theoretical Molecular Weight | 14.5 kDa | |
| Apparent Molecular Weight | The protein has a predicted MW of 14.5 kDa same as Bis-Tris PAGE result. | |
| Formulation | Lyophilized from 0.22μm filtered solution in 20mM Tris, 150mM NaCl (pH 8.0). | |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | |
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
The purity of Alpha Synuclein, Human is greater than 95% as determined by SEC-HPLC. ?
Alpha Synuclein, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. ?
| Target Background | Alpha-synuclein (α-synuclein) is a small, acidic protein containing 140 amino acids, highly expressed in the brain and primarily localized in the presynaptic terminals. It is found in high concentrations in Lewy Bodies, proteinaceous aggregates that constitute a typical histopathologic hallmark of Parkinson's disease. |
| Synonyms | Alpha-synuclein; NACP; SNCA; PARK1 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
